Physician profile
Robert Scott Libby
NPI 1225534316
$4,635.77
in general payments reported to CMS, 2019-2025
13 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,733 · 2024: $559 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,635.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,201.21 | 2023-2024 | Davinci Xi |
| Boston Scientific Corporation | $603.73 | 2023-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Lumenis Pulse 120h |
| Laborie Medical Technologies Corp. | $165.35 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $152.85 | 2023-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $139.12 | 2023-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $92.12 | 2024-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $87.60 | 2023 | Interstim |
| Merck Sharp & Dohme LLC | $49.80 | 2025 | Keytruda, Keytruda Qlex, Lynparza |
| Urogen Pharma, INC. | $48.53 | 2025 | |
| Janssen Biotech, INC. | $46.68 | 2025 | Erleada |
| Abc Home Medical Supply, INC. | $18.57 | 2024 | |
| Abbvie INC. | $16.50 | 2025 | |
| Coloplast Corp | $13.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Libby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.